Franz Steffen, Schulz Barbara, Wang Haili, Gottschalk Sabine, Grüter Florian, Friedrich Jochen, Glaesener Jean-Jacques, Bock Fritjof, Schott Cordelia, Müller Rachel, Schultes Kevin, Landmann Gunther, Gerner Hans Jürgen, Dietz Volker, Treede Rolf-Detlef, Weidner Norbert
Spinal Cord Injury Center, Heidelberg University Hospital, Heidelberg, Germany.
BG Klinikum Bergmannstrost, Abteilung Medizinische Psychologie, Spezielle Traumatherapie (DeGPT), Hypnotherapie und Hypnose (DGH), Halle, Germany.
Ger Med Sci. 2019 Jun 17;17:Doc05. doi: 10.3205/000271. eCollection 2019.
Pain is a prominent complication in spinal cord injury (SCI). It can either occur as a direct or as an indirect consequence of SCI and it often heavily influences the quality of life of affected individuals. In SCI, nociceptive and neuropathic pain can equally emerge at the same time above or below the level of injury. Thus, classification and grading of pain is frequently difficult. Effective treatment of SCI-related pain in general and of neuropathic pain in particular is challenging. Current treatment options are sparse and their evidence is considered to be limited. Considering these aspects, a clinical practice guideline was developed as basis for an optimized, comprehensive and standardized pain management in SCI-related pain. The German-Speaking Medical Society for Spinal Cord Injury (Deutschsprachige Medizinische Gesellschaft für Paraplegiologie - DMGP) developed a clinical practice guideline that received consensus from seven further German-speaking medical societies and one patient organization. The evidence base from clinical trials and meta-analyses was summarized and subjected to a structured consensus-process in accordance with the regulations of the Association of Scientific Medical Societies in Germany (AWMF) and the methodological requirements of the "German instrument for methodological guideline appraisal". This consensus-based guideline (S2k classification according to the AWMF guidance manual and rules) resulted in seven on-topic statements and 17 specific recommendations relevant to the classification, assessment and therapy of pain directly or indirectly caused by SCI. Recommended therapeutic approaches comprise pharmacological (e.g. nonsteroidal anti-inflammatory drugs or anticonvulsants) and non-pharmacological (e.g. physical activity or psychotherapeutic techniques) strategies for both nociceptive and neuropathic pain. Assessment of SCI-related pain is standardized and respective methods in terms of examination, classification and grading of pain are already in use and validated in German language. In contrast, valid, evidence-based and efficient therapeutic options are limited and ask for further clinical studies, ideally randomized controlled trials and meta-analyses.
疼痛是脊髓损伤(SCI)的一个突出并发症。它既可以作为SCI的直接后果出现,也可以作为间接后果出现,并且常常严重影响受影响个体的生活质量。在SCI中,伤害性疼痛和神经性疼痛可在损伤平面之上或之下同时出现。因此,疼痛的分类和分级常常很困难。一般而言,有效治疗与SCI相关的疼痛,尤其是神经性疼痛具有挑战性。目前的治疗选择稀少,其证据被认为是有限的。考虑到这些方面,制定了一项临床实践指南,作为优化、全面和标准化的SCI相关疼痛管理的基础。德语脊髓损伤医学协会(Deutschsprachige Medizinische Gesellschaft für Paraplegiologie - DMGP)制定了一项临床实践指南,该指南获得了另外七个德语医学协会和一个患者组织的共识。总结了来自临床试验和荟萃分析的证据基础,并根据德国科学医学协会联合会(AWMF)的规定和“德国方法学指南评估工具”的方法学要求,进行了结构化的共识过程。这项基于共识的指南(根据AWMF指导手册和规则的S2k分类)产生了七条主题声明和17条与SCI直接或间接引起的疼痛的分类、评估和治疗相关的具体建议。推荐的治疗方法包括针对伤害性疼痛和神经性疼痛的药理学(如非甾体抗炎药或抗惊厥药)和非药理学(如体育活动或心理治疗技术)策略。SCI相关疼痛的评估是标准化的,疼痛检查、分类和分级方面的相应方法已经在使用并且已通过德语验证。相比之下,有效的、基于证据的和高效的治疗选择有限,需要进一步的临床研究,理想情况下是随机对照试验和荟萃分析。